Likewise, reviews of multi-national cohort studies performed before awareness of this IGF1R SNP contribution concluded that the general breast cancer risk-reducing impact of preeclampsia is modest (10–20%), if present at all [10]. Here, IGF1R is linked to preeclampsia.